P. Mommen

1.4k citations

41 papers · 1.1k indexed · h-index 18

Impact in

Oncology top 5%
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- Peptidase Inhibition and Analysis
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment

Papers in

Oncology 28
- Lung Cancer Research Studies 25
- Drug Transport and Resistance Mechanisms 2
Pulmonary and Respiratory Medicine 30
- Lung Cancer Treatments and Mutations 27
- Lung Cancer Diagnosis and Treatment 9
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2

Co-authors: J Thiriaux Jean‐Paul Sculier Marianne Paesmans O Van Cutsem G. Bureau R Sergysels G Dabouis P Libert
Journals: Lung Cancer (13 papers)European Journal of Cancer (6 papers)Annals of Oncology (6 papers)Journal of Clinical Oncology (3 papers)British Journal of Cancer (2 papers)
Partner nations: Belgium France Spain

In The Last Decade

P. Mommen

39 papers receiving 1.1k citations

Peers

Countries citing papers authored by P. Mommen

Since Specialization

Citations

This map shows the geographic impact of P. Mommen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Mommen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Mommen more than expected).

Fields of papers citing papers by P. Mommen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Mommen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Mommen. The network helps show where P. Mommen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P. Mommen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Mommen Line = papers co-authored together P. Mommen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiation Therapy for Nonsmall-Cell Lung Cancer Antibiotics and chemotherapy/Antibiotica et chemotherapia ·P. Van Houtte, Jean Klášterský, A. Renaud, J. Michel, G. Vandermoten, Sridhar Bilvam, J.P. Sculier, Jacques Devriendt, P. Mommen	2015	0
2	A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma Lung Cancer ·T. Berghmans, J.J. Lafitte, Marianne Paesmans, B. Stach, M.C. Berchier, Wilco C. E. P. Verberk, 誠林南山, T. Collon, P. Mommen, J.P. Sculier	2005	22
3	Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy Lung Cancer ·Thierry Berghmans, J.J. Lafitte, J Thiriaux, Wahyu Purbo Juwono, J. Lecomte, Anna Efremidis, George Koumakis, V. Giner, Michel Richez, J L Corhay, Dayron Ortega, Philippe Lothaire, P. Mommen, Vincent Ninane, Jean‐Paul Sculier	2004	19
4	A phase II randomised trial comparing the cisplatin–etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer Annals of Oncology ·Jean‐Paul Sculier, J.J. Lafitte, J. Lecomte, Thierry Berghmans, J Thiriaux, O Van Cutsem, Anna Efremidis, Vincent Ninane, Marianne Paesmans, P. Mommen, Jean Klášterský	2002	16
5	A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy Lung Cancer ·Jean‐Paul Sculier, Thierry Berghmans, J.J. Lafitte, Michel Richez, S. Konishi, O Van Cutsem, Vincent Ninane, P. Mommen, M Paesmans, Annette Feliberty Ruiz	2002	21
6	A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer Annals of Oncology ·Jean‐Paul Sculier, J.J. Lafitte, J. Lecomte, Thierry Berghmans, J Thiriaux, Luiza Bordignon Cypriano, Anna Efremidis, C.G. Alexopoulos, S. Konishi, Vincent Ninane, P. Mommen, Marianne Paesmans, Jean Klášterský	2002	37
7	Prognostic factors for patients with small cell lung carcinoma Cancer ·Marianne Paesmans, Jean‐Paul Sculier, J. Lecomte, J Thiriaux, P Libert, R Sergysels, G. Bureau, G Dabouis, O Van Cutsem, P. Mommen, Vincent Ninane, Jean Klášterský, (unknown)	2000	179
8	A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer Lung Cancer ·J.P. Sculier, J.J. Lafitte, T. Berghmans, J Thiriaux, J. Lecomte, Anna Efremidis, Vincent Ninane, Marianne Paesmans, P. Mommen, Jean Klášterský	2000	41
9	Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer British Journal of Cancer ·Sculier Jp, J.J. Lafitte, M Paesmans, J Thiriaux, C.G. Alexopoulos, 園江落合, J Schmerber, George Koumakis, Luiza Bordignon Cypriano, Adwoa Yeboaa Owusu, T. Berghmans, P. Mommen, Vincent Ninane, Jean Klášterský	2000	18
10	Cisplatin-carboplatin-gemcitabine or ifosfamide-gemcitabine in advanced non-small cell lung carcinoma: two pilot studies. PubMed ·T. Berghmans, Jean Klášterský, G Fritsche, P. Mommen, Jean‐Paul Sculier	2000	3
11	A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer European Journal of Cancer ·J.P. Sculier, Marianne Paesmans, J Thiriaux, J. Lecomte, G. Bureau, V. Giner, George Koumakis, J.J. Lafitte, M.C. Berchier, C.G. Alexopoulos, Adwoa Yeboaa Owusu, P. Mommen, Vincent Ninane, Jean Klášterský	1999	20
12	Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party. Journal of Clinical Oncology ·Sculier Jp, Marianne Paesmans, J Thiriaux, J. Lecomte, G. Bureau, V. Giner, Anna Efremidis, J.J. Lafitte, M.C. Berchier, C.G. Alexopoulos, Adwoa Yeboaa Owusu, P. Mommen, Vincent Ninane, Jean Klášterský	1998	24
13	Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy Lung Cancer ·Jean‐Paul Sculier, Marianne Paesmans, Vincent Ninane, V. Giner, G. Bureau, J.J. Lafitte, 園江落合, J Thiriaux, O Van Cutsem, S. Konishi, M.C. Berchier, A. Golubсzov, P. Mommen, P. Van Houtte, Jean Klášterský	1998	11
14	Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party. Journal of Clinical Oncology ·Jean‐Paul Sculier, M Paesmans, G. Bureau, V. Giner, J. Lecomte, J. Michel, M.C. Berchier, O Van Cutsem, Kanthi Srirengan, Frode Krøll, R Sergysels, P. Mommen, Jean Klášterský	1996	54
15	Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC) Lung Cancer ·Xuechuan He, Jean‐Paul Sculier, Marianne Paesmans, Michel Richez, G. Bureau, G Dabouis, J. Lecomte, J. Michel, O Van Cutsem, J Schmerber, V. Giner, M.C. Berchier, R Sergysels, P. Mommen, Jean Klášterský	1996	24
16	Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology ·Marianne Paesmans, Jean‐Paul Sculier, P Libert, G. Bureau, G Dabouis, J Thiriaux, J. Michel, O Van Cutsem, R Sergysels, P. Mommen	1995	341
17	Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer European Journal of Cancer ·Jean‐Paul Sculier, M Paesmans, P Libert, G. Bureau, G Dabouis, J Thiriaux, Eric Klein, O Van Cutsem, J Schmerber, V. Giner, M.C. Berchier, R Sergysels, P. Mommen, Jean Klášterský	1994	28
18	A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer Annals of Oncology ·Jean‐Paul Sculier, Jean Klášterský, P Libert, P Ravez, J Thiriaux, J. Lecomte, G. Bureau, G. Vandermoten, G Dabouis, J. Michel, J Schmerber, R Sergysels, D. Becquart, P. Mommen, M. Paesmans	1990	18
19	Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer European Journal of Cancer and Clinical Oncology ·Jean‐Paul Sculier, Jean Klášterský, D. Becquart, G. Vandermoten, P. Van Houtte, P Rocmans, J Thiriaux, E Longeval, P Ravez, P Libert, Irvin Nicholas, Eric Klein, M Mairesse, P. Mommen, Otilia Dalesio	1988	10
20	Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: A pilot study by the lung cancer working party (Belgium) Lung Cancer ·Jean‐Paul Sculier, Jean Klášterský, W Obendorf, G. Vandermoten, P Rocmans, P Libert, P Ravez, D. Becquart, P. Mommen, Otilia Dalesio	1987	12

About P. Mommen

P. Mommen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Hepatology and Otorhinolaryngology, having authored 41 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (25 papers), Neuroendocrine Tumor Research Advances (12 papers), Lung Cancer Diagnosis and Treatment (9 papers), Cancer therapeutics and mechanisms (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Oncology (833 citations), Pulmonary and Respiratory Medicine (717 citations), Epidemiology (250 citations), Cancer Research (91 citations) and Otorhinolaryngology (26 citations). P. Mommen has collaborated with scholars based in Belgium, France and Spain. Frequent co-authors include J Thiriaux, Jean‐Paul Sculier, Marianne Paesmans, O Van Cutsem, G. Bureau, R Sergysels, G Dabouis, P Libert, Jean Klášterský and J. Michel. Their work appears in journals such as Lung Cancer, European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact